Original Research

Repeatability of the Maximum Standard Uptake Value (SUVmax) in FDG PET
  • Henry Lindholm
  • Johan Staaf
  • Hans Jacobsson
  • Fredrik Brolin
  • Robert Hatherly
  • Alejandro Sa^nchez-Crespo
Mol Imaging Radionucl Ther 2014; 23: 16-20 DOI: 10.4274/Mirt.76376 PMID:24653930
Does Metastatic Lymph Node SUVmax Predict Survival in Patients with Esophageal Cancer?
  • Betül Vatankulu
  • Yasemin Şanlı
  • Esra Kaytan Sağlam
  • Serkan Kuyumcu
  • Zeynep Gözde Özkan
  • Ebru Yılmaz
  • Sevim Purisa
  • Işık Adalet
Mol Imaging Radionucl Ther 2015; 24: 120-127 DOI: 10.4274/mirt.36744 PMID:27529887

Original Article

The Evaluation of Preoperative 18F-FDG PET/CT in Patients with Endometrial Cancer and the Correlation Between PET Parameters and Postoperative Pathology Results
  • Özge Vural Topuz
  • Ayşegül Aksu
  • Sadife Rüya Erinç
  • Nedim Tokgözoğlu
  • Müge Öner Tamam
Mol Imaging Radionucl Ther 2022; 31: 16-22 DOI: 10.4274/mirt.galenos.2021.33154 PMID:35114747
Comparison of SUVmax Values Obtained from F-18 FDG PET/CT and Cell-free DNA Levels Measured from Plasma in Oncology Patients
  • Fatmanur Çelik
  • Yusuf Ziya Tan
  • Semra Özdemir
  • Fatma Sılan
Mol Imaging Radionucl Ther 2019; 28: 46-52 DOI: 10.4274/mirt.galenos.2019.60352 PMID:31234620
Utility of FDG PET/CT in the Management of Primary Testicular Lymphoma
  • Kürşat Okuyucu
  • Semra İnce
  • Engin Alagöz
  • Erman Ataş
  • Nuri Arslan
Mol Imaging Radionucl Ther 2018; 27: 61-65 DOI: 10.4274/mirt.14227 PMID:29889027
The Impact of Primary Tumor and Locoregional Metastatic Lymph Node SUVmax on Predicting Survival in Patients with Rectal Cancer
  • Göksel Alçın
  • Yasemin Şanlı
  • Gülçin Yeğen
  • Esra Kaytan Sağlam
  • Tevfik Fikret Çermik
Mol Imaging Radionucl Ther 2020; 29: 65-71 DOI: 10.4274/mirt.galenos.2020.40316 PMID:32368877
The Role of Ga-68 PSMA PET/CT Scan on Differentiating of Oligometastatic and High Risk Prostate Cancer
  • Mehmet Erdoğan
  • Emine Elif Özkan
  • Sefa Alperen Öztürk
  • Mustafa Yıldız
  • Sevim Süreyya Şengül
Mol Imaging Radionucl Ther 2020; 29: 98-104 DOI: 10.4274/mirt.galenos.2020.89421 PMID:33094571
The Use of 18F-FDG PET/CT in Patients with Recurrent Differentiated Thyroid Cancer
  • Özgül Ekmekçioğlu
Mol Imaging Radionucl Ther 2021; 30: 137-143 DOI: 10.4274/mirt.galenos.2021.02360 PMID:34658228
Prognostic Prediction of BRCA Mutations by 18F-FDG PET/CT SUVmax in Breast Cancer
  • Semra Özdemir
  • Fatma Sılan
  • Mehmet Yılmaz Akgün
  • Nilgün Aracı
  • İsmail Çırpan
  • Fulya Koç Öztürk
  • Öztürk Özdemir
Mol Imaging Radionucl Ther 2021; 30: 158-168 DOI: 10.4274/mirt.galenos.2021.82584 PMID:34658299